Viemed Healthcare, Inc.
Символ: VMD
NASDAQ
9.38
USDПазарна цена днес
31.3789
Съотношение P/E
0.0542
Коефициент PEG
361.03M
MRK Cap
- 0.00%
Доходност на DIV
Viemed Healthcare, Inc. (VMD) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 56.62 | 12.8 | 16.9 | 28.4 | ||||||||
balance-sheet.row.short-term-investments | -2.16 | 0 | -2 | 0 | ||||||||
balance-sheet.row.net-receivables | 71.52 | 18.4 | 15.4 | 14.7 | ||||||||
balance-sheet.row.inventory | 17.2 | 4.6 | 3.6 | 2.5 | ||||||||
balance-sheet.row.other-current-assets | 11.34 | 2.4 | 3.8 | 1.7 | ||||||||
balance-sheet.row.total-current-assets | 156.69 | 38.2 | 39.7 | 47.3 | ||||||||
balance-sheet.row.property-plant-equipment-net | 293.25 | 76.5 | 68.4 | 62.8 | ||||||||
balance-sheet.row.goodwill | 89.08 | 29.6 | 0 | 0 | ||||||||
balance-sheet.row.intangible-assets | 1.94 | 0.6 | 0 | 0 | ||||||||
balance-sheet.row.goodwill-and-intangible-assets | 91.17 | 30.3 | 0 | 0 | ||||||||
balance-sheet.row.long-term-investments | 15.92 | 3.9 | 4.2 | 2.2 | ||||||||
balance-sheet.row.tax-assets | 16.13 | 4.5 | 3.1 | 4.8 | ||||||||
balance-sheet.row.other-non-current-assets | 4.1 | 0.7 | 1.6 | 0.9 | ||||||||
balance-sheet.row.total-non-current-assets | 420.57 | 115.9 | 77.3 | 70.7 | ||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-assets | 577.25 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.account-payables | 26.61 | 4.2 | 2.6 | 3.2 | ||||||||
balance-sheet.row.short-term-debt | 8.74 | 2 | 0.5 | 1.9 | ||||||||
balance-sheet.row.tax-payables | 3.62 | 2.1 | 0 | 0 | ||||||||
balance-sheet.row.long-term-debt-total | 27.02 | 6 | 0.2 | 4.6 | ||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||
balance-sheet.row.other-current-liab | 60.11 | 19.6 | 11.1 | 8.9 | ||||||||
balance-sheet.row.total-non-current-liabilities | 32.07 | 8.8 | 1.1 | 5.3 | ||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.capital-lease-obligations | 4.89 | 2.3 | 0.7 | 0.7 | ||||||||
balance-sheet.row.total-liab | 150.58 | 40.8 | 19.9 | 23.1 | ||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0.3 | 0 | ||||||||
balance-sheet.row.common-stock | 72.19 | 18.6 | 15.1 | 14 | ||||||||
balance-sheet.row.retained-earnings | 299.13 | 79.1 | 69.8 | 73.3 | ||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 0 | -0.3 | -0.3 | ||||||||
balance-sheet.row.other-total-stockholders-equity | 55.36 | 15.6 | 12.1 | 7.7 | ||||||||
balance-sheet.row.total-stockholders-equity | 426.67 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 577.25 | 154.1 | 117 | 118 | ||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||
balance-sheet.row.total-equity | 426.67 | 113.3 | 97.1 | 94.8 | ||||||||
balance-sheet.row.total-liabilities-and-total-equity | 577.25 | - | - | - | ||||||||
Total Investments | 13.75 | 3.9 | 2.2 | 2.2 | ||||||||
balance-sheet.row.total-debt | 38.07 | 10.3 | 0.7 | 6.5 | ||||||||
balance-sheet.row.net-debt | -18.55 | -2.5 | -16.2 | -21.9 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 10.34 | 10.4 | 6.2 | 9.1 | ||||||||
cash-flows.row.depreciation-and-amortization | 22.05 | 22.3 | 15.6 | 11.3 | ||||||||
cash-flows.row.deferred-income-tax | -5.42 | -1.5 | 1.7 | 3.9 | ||||||||
cash-flows.row.stock-based-compensation | 5.85 | 5.8 | 5.2 | 5.2 | ||||||||
cash-flows.row.change-in-working-capital | 7.93 | 7.9 | -10.1 | -13.6 | ||||||||
cash-flows.row.account-receivables | -1.08 | -1.1 | -12.6 | -7.3 | ||||||||
cash-flows.row.inventory | -0.48 | -0.5 | 0.3 | -0.2 | ||||||||
cash-flows.row.account-payables | -0.88 | -0.9 | -0.3 | 0.1 | ||||||||
cash-flows.row.other-working-capital | 10.37 | 10.4 | 2.4 | -6.1 | ||||||||
cash-flows.row.other-non-cash-items | 5.33 | 1 | 9.1 | 6.6 | ||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 46.08 | 0 | 0 | 0 | ||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -26.6 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.acquisitions-net | -27.76 | -26.5 | -0.1 | -0.6 | ||||||||
cash-flows.row.purchases-of-investments | -0.02 | 0 | -2 | -0.6 | ||||||||
cash-flows.row.sales-maturities-of-investments | 0.01 | -2.6 | 0 | 0.6 | ||||||||
cash-flows.row.other-investing-activites | 1.35 | 2.6 | 1.1 | 0.6 | ||||||||
cash-flows.row.net-cash-used-for-investing-activites | -53.02 | -53.1 | -24 | -19.7 | ||||||||
cash-flows.row.debt-repayment | -10.76 | -2.3 | -5.8 | -4 | ||||||||
cash-flows.row.common-stock-issued | 1.33 | 1.3 | 0.3 | 0.1 | ||||||||
cash-flows.row.common-stock-repurchased | -0.59 | -0.6 | -9.7 | -1.4 | ||||||||
cash-flows.row.dividends-paid | 0 | -0.4 | -0.3 | -0.1 | ||||||||
cash-flows.row.other-financing-activites | 13.68 | 4.9 | 0.3 | 0.1 | ||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 2.83 | 2.9 | -15.3 | -5.3 | ||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 14.43 | 0.1 | 0 | 0 | ||||||||
cash-flows.row.net-change-in-cash | -4.09 | 6.9 | -11.5 | -2.6 | ||||||||
cash-flows.row.cash-at-end-of-period | 56.62 | 12.8 | 16.9 | 28.4 | ||||||||
cash-flows.row.cash-at-beginning-of-period | 60.71 | 5.9 | 28.4 | 31 | ||||||||
cash-flows.row.operating-cash-flow | 46.08 | 46 | 27.7 | 22.5 | ||||||||
cash-flows.row.capital-expenditure | -26.6 | -26.6 | -22.9 | -19.7 | ||||||||
cash-flows.row.free-cash-flow | 19.48 | 19.5 | 4.8 | 2.8 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 184.41 | 186.4 | 138.8 | 117.1 | ||||||||
income-statement-row.row.cost-of-revenue | 71.19 | 72.9 | 54.2 | 43.7 | ||||||||
income-statement-row.row.gross-profit | 113.22 | 113.4 | 84.7 | 73.4 | ||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||
income-statement-row.row.research-development | 2.8 | - | - | - | ||||||||
income-statement-row.row.selling-general-administrative | 93.73 | - | - | - | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0.64 | - | - | - | ||||||||
income-statement-row.row.other-expenses | 0.17 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.operating-expenses | 98.03 | 97.6 | 76.1 | 61.4 | ||||||||
income-statement-row.row.cost-and-expenses | 169.22 | 170.6 | 130.2 | 105 | ||||||||
income-statement-row.row.interest-income | 0.31 | 0 | 0.2 | 0.3 | ||||||||
income-statement-row.row.interest-expense | 0.47 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.selling-and-marketing-expenses | 0.64 | - | - | - | ||||||||
income-statement-row.row.total-other-income-expensenet | -0.47 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||
income-statement-row.row.other-operating-expenses | 0.17 | 0.1 | 0 | -0.8 | ||||||||
income-statement-row.row.total-operating-expenses | -0.47 | -1.1 | 0.7 | 0.9 | ||||||||
income-statement-row.row.interest-expense | 0.47 | 0.4 | 0.2 | 0.3 | ||||||||
income-statement-row.row.depreciation-and-amortization | 22.01 | 22.3 | 16.3 | 12.2 | ||||||||
income-statement-row.row.ebitda-caps | 37.61 | - | - | - | ||||||||
income-statement-row.row.operating-income | 14.82 | 15.8 | 8.3 | 11.6 | ||||||||
income-statement-row.row.income-before-tax | 14.53 | 14.7 | 9 | 12.5 | ||||||||
income-statement-row.row.income-tax-expense | 4.19 | 4.2 | 2.8 | 3.4 | ||||||||
income-statement-row.row.net-income | 10.24 | 10.2 | 6.2 | 9.1 |
Често задавани въпроси
Какво е Viemed Healthcare, Inc. (VMD) общи активи?
Viemed Healthcare, Inc. (VMD) общите активи са 154102510.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 101543346.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е 0.506.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е 0.506.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е 0.056.
Какъв е общият приход на предприятието?
Общият приход е 0.080.
Каква е Viemed Healthcare, Inc. (VMD) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е 10243000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 10271179.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 97637306.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 12773311.000.